Frequencies for first 10,000 rows of indi_pt variable in indi2011q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5Q MINUS SYNDROME | 1 0.01 0.01 ABDOMINAL DISCOMFORT | 13 0.13 0.14 ABDOMINAL DISTENSION | 1 0.01 0.15 ABDOMINAL PAIN | 11 0.11 0.26 ABDOMINAL PAIN LOWER | 1 0.01 0.27 ABDOMINAL PAIN UPPER | 7 0.07 0.34 ABSCESS | 3 0.03 0.37 ABSCESS FUNGAL | 1 0.01 0.38 ACNE | 99 0.99 1.37 ACQUIRED EPIDERMOLYSIS BULLOSA | 1 0.01 1.38 ACROMEGALY | 3 0.03 1.41 ACUTE CORONARY SYNDROME | 20 0.20 1.61 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 3 0.03 1.64 ACUTE GRAFT VERSUS HOST DISEASE | 6 0.06 1.70 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 2 0.02 1.72 ACUTE GRAFT VERSUS HOST DISEASE IN LI.. | 2 0.02 1.74 ACUTE LEUKAEMIA | 9 0.09 1.83 ACUTE LYMPHOCYTIC LEUKAEMIA | 26 0.26 2.09 ACUTE MYELOID LEUKAEMIA | 28 0.28 2.37 ACUTE MYOCARDIAL INFARCTION | 2 0.02 2.39 ACUTE PROMYELOCYTIC LEUKAEMIA | 8 0.08 2.47 ADENOCARCINOMA | 4 0.04 2.51 ADENOMYOSIS | 1 0.01 2.52 ADNEXA UTERI PAIN | 1 0.01 2.53 ADRENAL DISORDER | 1 0.01 2.54 ADVERSE DRUG REACTION | 3 0.03 2.57 ADVERSE REACTION | 1 0.01 2.58 AFFECTIVE DISORDER | 13 0.13 2.71 AGITATED DEPRESSION | 1 0.01 2.72 AGITATION | 8 0.08 2.80 ALCOHOL USE | 1 0.01 2.81 ALCOHOLISM | 2 0.02 2.83 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 2.84 AMAUROSIS | 1 0.01 2.85 AMENORRHOEA | 1 0.01 2.86 ANAEMIA | 17 0.17 3.03 ANAESTHESIA | 8 0.08 3.11 ANAESTHETIC PREMEDICATION | 3 0.03 3.14 ANALGESIC THERAPY | 11 0.11 3.25 ANEURYSM | 2 0.02 3.27 ANGINA PECTORIS | 21 0.21 3.48 ANGINA UNSTABLE | 1 0.01 3.49 ANGIOGRAM | 4 0.04 3.53 ANGIOPLASTY | 1 0.01 3.54 ANKYLOSING SPONDYLITIS | 23 0.23 3.77 ANTACID THERAPY | 1 0.01 3.78 ANTI-INFECTIVE THERAPY | 2 0.02 3.80 ANTIANDROGEN THERAPY | 1 0.01 3.81 ANTIBIOTIC PROPHYLAXIS | 16 0.16 3.97 ANTIBIOTIC THERAPY | 3 0.03 4.00 ANTICOAGULANT THERAPY | 19 0.19 4.19 ANTIDEPRESSANT THERAPY | 5 0.05 4.24 ANTIEMETIC SUPPORTIVE CARE | 2 0.02 4.26 ANTIFUNGAL PROPHYLAXIS | 13 0.13 4.39 ANTIFUNGAL TREATMENT | 2 0.02 4.41 ANTIINFLAMMATORY THERAPY | 4 0.04 4.45 ANTIOESTROGEN THERAPY | 1 0.01 4.46 ANTIPHOSPHOLIPID SYNDROME | 3 0.03 4.49 ANTIPYRESIS | 1 0.01 4.50 ANTIRETROVIRAL THERAPY | 9 0.09 4.59 ANTIVIRAL PROPHYLAXIS | 13 0.13 4.72 ANTIVIRAL TREATMENT | 2 0.02 4.74 ANXIETY | 69 0.69 5.43 ANXIETY DISORDER | 2 0.02 5.45 ANXIOLYTIC THERAPY | 1 0.01 5.46 AORTIC DISSECTION | 1 0.01 5.47 AORTIC VALVE INCOMPETENCE | 1 0.01 5.48 APLASIA PURE RED CELL | 1 0.01 5.49 APLASTIC ANAEMIA | 19 0.19 5.68 APPENDICITIS | 6 0.06 5.74 APPETITE DISORDER | 2 0.02 5.76 ARRHYTHMIA | 12 0.12 5.88 ARRHYTHMIA PROPHYLAXIS | 1 0.01 5.89 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 5.91 ARTERIAL THROMBOSIS | 1 0.01 5.92 ARTERIOGRAM CORONARY | 1 0.01 5.93 ARTHRALGIA | 16 0.16 6.09 ARTHRITIS | 28 0.28 6.37 ARTHRITIS BACTERIAL | 2 0.02 6.39 ARTHROPATHY | 3 0.03 6.42 ASCITES | 4 0.04 6.46 ASPERGILLOSIS | 7 0.07 6.53 ASTHENIA | 2 0.02 6.55 ASTHMA | 72 0.72 7.27 ATONIC URINARY BLADDER | 1 0.01 7.28 ATRIAL FIBRILLATION | 143 1.43 8.71 ATRIAL FLUTTER | 3 0.03 8.74 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 19 0.19 8.93 AUTISM | 5 0.05 8.98 AUTISM SPECTRUM DISORDER | 1 0.01 8.99 AUTOIMMUNE THROMBOCYTOPENIA | 1 0.01 9.00 AVIAN INFLUENZA | 1 0.01 9.01 B-CELL LYMPHOMA | 8 0.08 9.09 BACK INJURY | 2 0.02 9.11 BACK PAIN | 30 0.30 9.41 BACTERIAL INFECTION | 3 0.03 9.44 BACTERIURIA | 1 0.01 9.45 BALANCE DISORDER | 1 0.01 9.46 BARRETT'S OESOPHAGUS | 1 0.01 9.47 BEHCET'S SYNDROME | 1 0.01 9.48 BENIGN PROSTATIC HYPERPLASIA | 17 0.17 9.65 BILIARY ISCHAEMIA | 1 0.01 9.66 BIPOLAR DISORDER | 39 0.39 10.05 BIPOLAR I DISORDER | 6 0.06 10.11 BLADDER CANCER | 10 0.10 10.21 BLADDER DISORDER | 4 0.04 10.25 BLADDER DYSFUNCTION | 1 0.01 10.26 BLADDER PAIN | 1 0.01 10.27 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 10.28 BLISTER | 1 0.01 10.29 BLOOD CHOLESTEROL | 14 0.14 10.43 BLOOD CHOLESTEROL ABNORMAL | 6 0.06 10.49 BLOOD CHOLESTEROL DECREASED | 2 0.02 10.51 BLOOD CHOLESTEROL INCREASED | 83 0.83 11.34 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.35 BLOOD GLUCOSE INCREASED | 1 0.01 11.36 BLOOD IMMUNOGLOBULIN G DECREASED | 1 0.01 11.37 BLOOD POTASSIUM DECREASED | 1 0.01 11.38 BLOOD PRESSURE | 33 0.33 11.71 BLOOD PRESSURE ABNORMAL | 5 0.05 11.76 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 11.77 BLOOD PRESSURE INCREASED | 7 0.07 11.84 BLOOD TESTOSTERONE DECREASED | 2 0.02 11.86 BLOOD TRIGLYCERIDES ABNORMAL | 2 0.02 11.88 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 11.92 BLOOD URIC ACID INCREASED | 1 0.01 11.93 BODY HEIGHT BELOW NORMAL | 1 0.01 11.94 BONE DENSITY DECREASED | 2 0.02 11.96 BONE DISORDER | 2 0.02 11.98 BONE LESION | 1 0.01 11.99 BONE MARROW CONDITIONING REGIMEN | 28 0.28 12.27 BONE MARROW TRANSPLANT | 5 0.05 12.32 BONE PAIN | 6 0.06 12.38 BRAIN MASS | 1 0.01 12.39 BRAIN NEOPLASM MALIGNANT | 1 0.01 12.40 BRAIN STEM GLIOMA | 2 0.02 12.42 BREAKTHROUGH PAIN | 2 0.02 12.44 BREAST CANCER | 79 0.79 13.23 BREAST CANCER FEMALE | 1 0.01 13.24 BREAST CANCER METASTATIC | 14 0.14 13.38 BREAST CANCER STAGE IV | 2 0.02 13.40 BREAST NEOPLASM | 2 0.02 13.42 BRONCHIECTASIS | 1 0.01 13.43 BRONCHIOLITIS | 1 0.01 13.44 BRONCHIOLOALVEOLAR CARCINOMA | 2 0.02 13.46 BRONCHITIS | 28 0.28 13.74 BRONCHITIS CHRONIC | 3 0.03 13.77 BRONCHOPULMONARY ASPERGILLOSIS | 7 0.07 13.84 BURSITIS | 1 0.01 13.85 CACHEXIA | 1 0.01 13.86 CANCER PAIN | 14 0.14 14.00 CANDIDIASIS | 8 0.08 14.08 CARCINOID SYNDROME | 7 0.07 14.15 CARCINOID TUMOUR | 80 0.80 14.95 CARDIAC ARREST | 3 0.03 14.98 CARDIAC DISORDER | 33 0.33 15.31 CARDIAC FAILURE | 15 0.15 15.46 CARDIAC FAILURE CHRONIC | 1 0.01 15.47 CARDIAC FAILURE CONGESTIVE | 4 0.04 15.51 CARDIAC INFECTION | 1 0.01 15.52 CARDIAC OPERATION | 1 0.01 15.53 CARDIOMYOPATHY | 2 0.02 15.55 CARDIOVASCULAR DISORDER | 3 0.03 15.58 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 15.62 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 15.63 CASTLEMAN'S DISEASE | 1 0.01 15.64 CATAPLEXY | 2 0.02 15.66 CATHETERISATION CARDIAC | 1 0.01 15.67 CELLULITIS | 6 0.06 15.73 CEREBRAL ARTERIOSCLEROSIS | 2 0.02 15.75 CEREBRAL INFARCTION | 4 0.04 15.79 CEREBRAL ISCHAEMIA | 1 0.01 15.80 CEREBROVASCULAR ACCIDENT | 5 0.05 15.85 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 14 0.14 15.99 CHELATION THERAPY | 2 0.02 16.01 CHEMOTHERAPY | 9 0.09 16.10 CHEST PAIN | 5 0.05 16.15 CHILLS | 1 0.01 16.16 CHOLECYSTITIS | 2 0.02 16.18 CHOLECYSTITIS INFECTIVE | 1 0.01 16.19 CHORIOAMNIONITIS | 1 0.01 16.20 CHOROIDAL NEOVASCULARISATION | 1 0.01 16.21 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 16.22 CHRONIC GRAFT VERSUS HOST DISEASE | 1 0.01 16.23 CHRONIC GRANULOMATOUS DISEASE | 1 0.01 16.24 CHRONIC LYMPHOCYTIC LEUKAEMIA | 43 0.43 16.67 CHRONIC MYELOID LEUKAEMIA | 40 0.40 17.07 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 56 0.56 17.63 CHRONIC SINUSITIS | 3 0.03 17.66 COAGULOPATHY | 2 0.02 17.68 COCCIDIOIDOMYCOSIS | 2 0.02 17.70 COELIAC DISEASE | 1 0.01 17.71 COGNITIVE DISORDER | 1 0.01 17.72 COLITIS | 9 0.09 17.81 COLITIS ULCERATIVE | 21 0.21 18.02 COLON CANCER | 11 0.11 18.13 COLON CANCER METASTATIC | 19 0.19 18.32 COLON CANCER RECURRENT | 1 0.01 18.33 COLON CANCER STAGE III | 1 0.01 18.34 COLONY STIMULATING FACTOR PROPHYLAXIS | 1 0.01 18.35 COLORECTAL CANCER | 22 0.22 18.57 COLORECTAL CANCER METASTATIC | 6 0.06 18.63 COLORECTAL CANCER STAGE IV | 5 0.05 18.68 COLOSTOMY | 6 0.06 18.74 COMPUTERISED TOMOGRAM | 4 0.04 18.78 CONDUCTION DISORDER | 1 0.01 18.79 CONFUSIONAL STATE | 1 0.01 18.80 CONGENITAL CYSTIC KIDNEY DISEASE | 35 0.35 19.15 CONGESTIVE CARDIOMYOPATHY | 1 0.01 19.16 CONSTIPATION | 36 0.36 19.52 CONSTIPATION PROPHYLAXIS | 2 0.02 19.54 CONTRACEPTION | 70 0.70 20.24 CONVULSION | 30 0.30 20.54 CONVULSION PROPHYLAXIS | 2 0.02 20.56 CORD BLOOD TRANSPLANT THERAPY | 4 0.04 20.60 CORNEAL ENDOTHELIITIS | 3 0.03 20.63 CORONARY ANGIOPLASTY | 1 0.01 20.64 CORONARY ARTERIAL STENT INSERTION | 3 0.03 20.67 CORONARY ARTERY BYPASS | 2 0.02 20.69 CORONARY ARTERY DISEASE | 22 0.22 20.91 CORONARY ARTERY OCCLUSION | 1 0.01 20.92 COUGH | 5 0.05 20.97 CROHN'S DISEASE | 85 0.85 21.82 CRYPTOCOCCOSIS | 2 0.02 21.84 CYSTIC FIBROSIS | 18 0.18 22.02 CYSTITIS | 2 0.02 22.04 CYSTITIS NONINFECTIVE | 1 0.01 22.05 CYTOMEGALOVIRUS INFECTION | 4 0.04 22.09 DECREASED APPETITE | 2 0.02 22.11 DECREASED IMMUNE RESPONSIVENESS | 1 0.01 22.12 DEEP VEIN THROMBOSIS | 10 0.10 22.22 DEHYDRATION | 2 0.02 22.24 DELIRIUM | 3 0.03 22.27 DELUSION | 3 0.03 22.30 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 3 0.03 22.33 DEMENTIA | 1 0.01 22.34 DEMENTIA ALZHEIMER'S TYPE | 10 0.10 22.44 DEMENTIA WITH LEWY BODIES | 1 0.01 22.45 DENTAL CARE | 3 0.03 22.48 DEPRESSION | 152 1.52 24.00 DEPRESSIVE SYMPTOM | 1 0.01 24.01 DERMATITIS | 2 0.02 24.03 DERMATITIS ATOPIC | 6 0.06 24.09 DERMATOFIBROSARCOMA | 1 0.01 24.10 DERMATOMYOSITIS | 1 0.01 24.11 DEVICE RELATED INFECTION | 2 0.02 24.13 DIABETES INSIPIDUS | 1 0.01 24.14 DIABETES MELLITUS | 192 1.92 26.06 DIABETIC NEUROPATHY | 2 0.02 26.08 DIABETIC RETINOPATHY | 1 0.01 26.09 DIALYSIS | 1 0.01 26.10 DIARRHOEA | 10 0.10 26.20 DIFFUSE LARGE B-CELL LYMPHOMA | 30 0.30 26.50 DISABILITY | 1 0.01 26.51 DISEASE PROGRESSION | 2 0.02 26.53 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 26.54 DISTURBANCE IN ATTENTION | 1 0.01 26.55 DIURETIC THERAPY | 11 0.11 26.66 DIVERTICULITIS | 1 0.01 26.67 DIVERTICULUM | 3 0.03 26.70 DIZZINESS | 2 0.02 26.72 DRUG ABUSE | 18 0.18 26.90 DRUG DEPENDENCE | 6 0.06 26.96 DRUG DETOXIFICATION | 2 0.02 26.98 DRUG EXPOSURE DURING PREGNANCY | 57 0.57 27.55 DRUG LEVEL | 4 0.04 27.59 DRUG THERAPY | 7 0.07 27.66 DRY EYE | 2 0.02 27.68 DRY SKIN | 3 0.03 27.71 DUODENAL ULCER | 2 0.02 27.73 DYSFUNCTIONAL UTERINE BLEEDING | 1 0.01 27.74 DYSLIPIDAEMIA | 8 0.08 27.82 DYSMENORRHOEA | 3 0.03 27.85 DYSPEPSIA | 18 0.18 28.03 DYSPHAGIA | 1 0.01 28.04 DYSPNOEA | 8 0.08 28.12 DYSURIA | 4 0.04 28.16 EAR INFECTION | 1 0.01 28.17 EAR PAIN | 1 0.01 28.18 ECZEMA | 1 0.01 28.19 ECZEMA EYELIDS | 1 0.01 28.20 ELECTROLYTE SUBSTITUTION THERAPY | 2 0.02 28.22 EMBOLIC STROKE | 2 0.02 28.24 EMOTIONAL DISORDER | 4 0.04 28.28 EMPHYSEMA | 7 0.07 28.35 ENDOCRINE NEOPLASM | 1 0.01 28.36 ENDOMETRIAL CANCER | 4 0.04 28.40 ENDOMETRIOSIS | 4 0.04 28.44 ENTEROCOCCAL SEPSIS | 2 0.02 28.46 ENTEROCOLITIS | 1 0.01 28.47 ENURESIS | 1 0.01 28.48 EPIDERMOLYSIS BULLOSA | 1 0.01 28.49 EPIDURAL ANAESTHESIA | 2 0.02 28.51 EPILEPSY | 30 0.30 28.81 ERECTILE DYSFUNCTION | 17 0.17 28.98 ERYTHEMA | 3 0.03 29.01 ERYTHRODERMIC PSORIASIS | 1 0.01 29.02 ESSENTIAL HYPERTENSION | 8 0.08 29.10 ESSENTIAL THROMBOCYTHAEMIA | 25 0.25 29.35 EVANS SYNDROME | 1 0.01 29.36 EX-TOBACCO USER | 2 0.02 29.38 EXTRAGONADAL PRIMARY GERM CELL TUMOUR.. | 4 0.04 29.42 EXTRAPYRAMIDAL DISORDER | 2 0.02 29.44 EYE ALLERGY | 1 0.01 29.45 EYE DISORDER | 2 0.02 29.47 EYE INFECTION | 1 0.01 29.48 EYE INFLAMMATION | 1 0.01 29.49 FABRY'S DISEASE | 1 0.01 29.50 FACIAL PARESIS | 1 0.01 29.51 FAECES HARD | 1 0.01 29.52 FATIGUE | 4 0.04 29.56 FEBRILE BONE MARROW APLASIA | 4 0.04 29.60 FEBRILE CONVULSION | 1 0.01 29.61 FEBRILE NEUTROPENIA | 4 0.04 29.65 FEELING ABNORMAL | 1 0.01 29.66 FEMORAL ARTERY OCCLUSION | 2 0.02 29.68 FIBROMYALGIA | 22 0.22 29.90 FLANK PAIN | 1 0.01 29.91 FLATULENCE | 2 0.02 29.93 FLUID RETENTION | 9 0.09 30.02 FOOT AMPUTATION | 1 0.01 30.03 FOOT DEFORMITY | 1 0.01 30.04 FORCED EXPIRATORY VOLUME DECREASED | 1 0.01 30.05 FUNGAL INFECTION | 3 0.03 30.08 FURUNCLE | 2 0.02 30.10 GAIT DISTURBANCE | 3 0.03 30.13 GALACTORRHOEA | 1 0.01 30.14 GALLBLADDER CANCER | 1 0.01 30.15 GANGRENE | 3 0.03 30.18 GASTRIC CANCER | 12 0.12 30.30 GASTRIC DISORDER | 9 0.09 30.39 GASTRIC HAEMORRHAGE | 1 0.01 30.40 GASTRIC ULCER | 14 0.14 30.54 GASTRITIS | 19 0.19 30.73 GASTRITIS PROPHYLAXIS | 10 0.10 30.83 GASTROENTERITIS | 1 0.01 30.84 GASTROINTESTINAL DISORDER | 1 0.01 30.85 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 30.86 GASTROINTESTINAL INFECTION | 1 0.01 30.87 GASTROINTESTINAL PAIN | 1 0.01 30.88 GASTROINTESTINAL STROMAL TUMOUR | 10 0.10 30.98 GASTROOESOPHAGEAL CANCER | 8 0.08 31.06 GASTROOESOPHAGEAL REFLUX DISEASE | 42 0.42 31.48 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 2 0.02 31.50 GAUCHER'S DISEASE | 3 0.03 31.53 GENERAL ANAESTHESIA | 2 0.02 31.55 GENERALISED ANXIETY DISORDER | 1 0.01 31.56 GENITAL HERPES | 2 0.02 31.58 GESTATIONAL DIABETES | 2 0.02 31.60 GLAUCOMA | 13 0.13 31.73 GLIOBLASTOMA | 14 0.14 31.87 GLIOBLASTOMA MULTIFORME | 1 0.01 31.88 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 31.90 GLYCOGEN STORAGE DISEASE TYPE II | 4 0.04 31.94 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 31.95 GOUT | 15 0.15 32.10 GOUTY ARTHRITIS | 1 0.01 32.11 GROWTH HORMONE DEFICIENCY | 4 0.04 32.15 HAEMANGIOMA | 1 0.01 32.16 HAEMATOPOIETIC NEOPLASM | 1 0.01 32.17 HAEMODIALYSIS | 3 0.03 32.20 HAEMOGLOBIN DECREASED | 1 0.01 32.21 HAEMOLYTIC ANAEMIA | 2 0.02 32.23 HAEMORRHAGE | 1 0.01 32.24 HAEMORRHOIDS | 1 0.01 32.25 HAEMOSIDEROSIS | 1 0.01 32.26 HAEMOSTASIS | 2 0.02 32.28 HALLUCINATION | 6 0.06 32.34 HALLUCINATION, AUDITORY | 1 0.01 32.35 HALLUCINATION, VISUAL | 1 0.01 32.36 HEAD AND NECK CANCER | 13 0.13 32.49 HEADACHE | 29 0.29 32.78 HEART RATE ABNORMAL | 1 0.01 32.79 HEART RATE INCREASED | 1 0.01 32.80 HEART RATE IRREGULAR | 5 0.05 32.85 HEART TRANSPLANT | 2 0.02 32.87 HEART VALVE REPLACEMENT | 1 0.01 32.88 HELICOBACTER INFECTION | 7 0.07 32.95 HEPATIC CANCER METASTATIC | 1 0.01 32.96 HEPATIC ENCEPHALOPATHY PROPHYLAXIS | 1 0.01 32.97 HEPATIC FUNCTION ABNORMAL | 3 0.03 33.00 HEPATIC LESION | 1 0.01 33.01 HEPATIC NEOPLASM MALIGNANT | 10 0.10 33.11 HEPATIC PAIN | 1 0.01 33.12 HEPATITIS B | 4 0.04 33.16 HEPATITIS C | 17 0.17 33.33 HEPATOBLASTOMA | 4 0.04 33.37 HERPES ZOSTER | 8 0.08 33.45 HIATUS HERNIA | 1 0.01 33.46 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 33.48 HIP FRACTURE | 1 0.01 33.49 HIV INFECTION | 81 0.81 34.30 HIV TEST POSITIVE | 2 0.02 34.32 HODGKIN'S DISEASE | 7 0.07 34.39 HORMONE REPLACEMENT THERAPY | 181 1.81 36.20 HORMONE SUPPRESSION THERAPY | 1 0.01 36.21 HORMONE THERAPY | 3 0.03 36.24 HOT FLUSH | 2 0.02 36.26 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 36.27 HYPERCALCAEMIA | 1 0.01 36.28 HYPERCHLORHYDRIA | 5 0.05 36.33 HYPERCHOLESTEROLAEMIA | 18 0.18 36.51 HYPEREOSINOPHILIC SYNDROME | 1 0.01 36.52 HYPERKALAEMIA | 2 0.02 36.54 HYPERLIPIDAEMIA | 32 0.32 36.86 HYPERPARATHYROIDISM SECONDARY | 4 0.04 36.90 HYPERPHOSPHATAEMIA | 15 0.15 37.05 HYPERSENSITIVITY | 17 0.17 37.22 HYPERTENSION | 437 4.37 41.59 HYPERTHERMIA | 1 0.01 41.60 HYPERTHYROIDISM | 2 0.02 41.62 HYPERTONIC BLADDER | 7 0.07 41.69 HYPERTRIGLYCERIDAEMIA | 2 0.02 41.71 HYPERURICAEMIA | 4 0.04 41.75 HYPERVIGILANCE | 1 0.01 41.76 HYPOAESTHESIA | 1 0.01 41.77 HYPOCALCAEMIA | 4 0.04 41.81 HYPOGONADISM | 1 0.01 41.82 HYPOKALAEMIA | 3 0.03 41.85 HYPOMAGNESAEMIA | 2 0.02 41.87 HYPOPITUITARISM | 6 0.06 41.93 HYPOTHYROIDISM | 37 0.37 42.30 HYPOVITAMINOSIS | 4 0.04 42.34 HYPOXIA | 1 0.01 42.35 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 42.36 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 41 0.41 42.77 ILL-DEFINED DISORDER | 121 1.21 43.98 IMMUNISATION | 1 0.01 43.99 IMMUNOSUPPRESSANT DRUG THERAPY | 6 0.06 44.05 IMMUNOSUPPRESSION | 8 0.08 44.13 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 44.14 IN VITRO FERTILISATION | 2 0.02 44.16 INCISIONAL DRAINAGE | 1 0.01 44.17 INCONTINENCE | 2 0.02 44.19 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 3 0.03 44.22 INDUCTION OF ANAESTHESIA | 3 0.03 44.25 INFECTION | 22 0.22 44.47 INFECTION PROPHYLAXIS | 37 0.37 44.84 INFLAMMATION | 2 0.02 44.86 INFLAMMATORY BOWEL DISEASE | 2 0.02 44.88 INFLUENZA | 6 0.06 44.94 INFLUENZA LIKE ILLNESS | 1 0.01 44.95 INJURY | 1 0.01 44.96 INSOMNIA | 41 0.41 45.37 INSULIN RESISTANCE | 1 0.01 45.38 INSULIN RESISTANT DIABETES | 1 0.01 45.39 INTENTIONAL OVERDOSE | 22 0.22 45.61 INTERVERTEBRAL DISC DISORDER | 1 0.01 45.62 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 45.67 INTERVERTEBRAL DISCITIS | 2 0.02 45.69 INTESTINAL DILATATION | 2 0.02 45.71 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 45.72 INTRACARDIAC THROMBUS | 1 0.01 45.73 INTRACRANIAL ANEURYSM | 1 0.01 45.74 INTRACRANIAL PRESSURE INCREASED | 1 0.01 45.75 INTRAVENOUS CATHETER MANAGEMENT | 3 0.03 45.78 IRON DEFICIENCY ANAEMIA | 3 0.03 45.81 IRON METABOLISM DISORDER | 1 0.01 45.82 IRON OVERLOAD | 10 0.10 45.92 IRRITABLE BOWEL SYNDROME | 4 0.04 45.96 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 45.98 ISCHAEMIC STROKE | 1 0.01 45.99 JOINT STIFFNESS | 1 0.01 46.00 JOINT SWELLING | 1 0.01 46.01 JUVENILE ARTHRITIS | 7 0.07 46.08 KERATITIS FUNGAL | 12 0.12 46.20 KIDNEY INFECTION | 1 0.01 46.21 KNEE ARTHROPLASTY | 3 0.03 46.24 LABYRINTHITIS | 1 0.01 46.25 LACTOSE INTOLERANCE | 1 0.01 46.26 LARGE GRANULAR LYMPHOCYTOSIS | 1 0.01 46.27 LARGE INTESTINE CARCINOMA | 11 0.11 46.38 LENNOX-GASTAUT SYNDROME | 3 0.03 46.41 LEUKOPENIA | 1 0.01 46.42 LICHEN PLANUS | 1 0.01 46.43 LIVER ABSCESS | 2 0.02 46.45 LIVER TRANSPLANT | 9 0.09 46.54 LOCAL ANAESTHESIA | 4 0.04 46.58 LOCALISED INTRAABDOMINAL FLUID COLLEC.. | 2 0.02 46.60 LUNG ADENOCARCINOMA | 5 0.05 46.65 LUNG DISORDER | 2 0.02 46.67 LUNG INFECTION | 1 0.01 46.68 LUNG NEOPLASM MALIGNANT | 2 0.02 46.70 LUNG TRANSPLANT | 22 0.22 46.92 LUNG TRANSPLANT REJECTION | 1 0.01 46.93 LYMPHOMA | 3 0.03 46.96 MACULAR DEGENERATION | 17 0.17 47.13 MACULAR OEDEMA | 2 0.02 47.15 MAJOR DEPRESSION | 11 0.11 47.26 MALAISE | 1 0.01 47.27 MALARIA PROPHYLAXIS | 2 0.02 47.29 MALIGNANT ASCITES | 1 0.01 47.30 MALIGNANT LYMPHOID NEOPLASM | 1 0.01 47.31 MALIGNANT MELANOMA | 1 0.01 47.32 MALNUTRITION | 1 0.01 47.33 MANIA | 2 0.02 47.35 MANTLE CELL LYMPHOMA | 4 0.04 47.39 MASTITIS | 1 0.01 47.40 MATERNAL THERAPY TO ENHANCE FOETAL LU.. | 3 0.03 47.43 MEDICAL DIET | 5 0.05 47.48 MEDICATION DILUTION | 1 0.01 47.49 MEDULLOBLASTOMA | 1 0.01 47.50 MENOPAUSAL DISORDER | 1 0.01 47.51 MENOPAUSAL SYMPTOMS | 7 0.07 47.58 MENOPAUSE | 4 0.04 47.62 MENORRHAGIA | 6 0.06 47.68 MENSTRUAL CYCLE MANAGEMENT | 8 0.08 47.76 MENSTRUAL DISORDER | 1 0.01 47.77 MENSTRUATION IRREGULAR | 7 0.07 47.84 MENTAL DISORDER | 1 0.01 47.85 MENTAL RETARDATION | 1 0.01 47.86 METABOLIC ACIDOSIS | 1 0.01 47.87 METASTASES TO BONE | 21 0.21 48.08 METASTASES TO LUNG | 1 0.01 48.09 METASTASIS | 1 0.01 48.10 METASTATIC CARCINOID TUMOUR | 2 0.02 48.12 METASTATIC PAIN | 1 0.01 48.13 METASTATIC RENAL CELL CARCINOMA | 11 0.11 48.24 MIGRAINE | 28 0.28 48.52 MIGRAINE PROPHYLAXIS | 5 0.05 48.57 MIGRAINE WITHOUT AURA | 1 0.01 48.58 MINERAL SUPPLEMENTATION | 10 0.10 48.68 MITRAL VALVE PROLAPSE | 1 0.01 48.69 MITRAL VALVE REPLACEMENT | 1 0.01 48.70 MOBILITY DECREASED | 1 0.01 48.71 MOOD ALTERED | 6 0.06 48.77 MUCOPOLYSACCHARIDOSIS II | 1 0.01 48.78 MULTIPLE ALLERGIES | 3 0.03 48.81 MULTIPLE MYELOMA | 114 1.14 49.95 MULTIPLE SCLEROSIS | 571 5.71 55.66 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 55.68 MUSCLE INJURY | 1 0.01 55.69 MUSCLE RELAXANT THERAPY | 3 0.03 55.72 MUSCLE SPASMS | 18 0.18 55.90 MUSCLE SPASTICITY | 2 0.02 55.92 MUSCULOSKELETAL CHEST PAIN | 4 0.04 55.96 MUSCULOSKELETAL DISORDER | 2 0.02 55.98 MUSCULOSKELETAL PAIN | 4 0.04 56.02 MUSCULOSKELETAL STIFFNESS | 3 0.03 56.05 MYASTHENIA GRAVIS | 4 0.04 56.09 MYCOBACTERIUM ABSCESSUS INFECTION | 1 0.01 56.10 MYELODYSPLASTIC SYNDROME | 27 0.27 56.37 MYELOFIBROSIS | 11 0.11 56.48 MYOCARDIAL INFARCTION | 14 0.14 56.62 MYOCARDIAL ISCHAEMIA | 1 0.01 56.63 MYOSITIS | 3 0.03 56.66 NARCOLEPSY | 1 0.01 56.67 NASAL CONGESTION | 6 0.06 56.73 NASOPHARYNGEAL CANCER | 1 0.01 56.74 NASOPHARYNGITIS | 6 0.06 56.80 NAUSEA | 26 0.26 57.06 NECK PAIN | 3 0.03 57.09 NEOPLASM | 3 0.03 57.12 NEOPLASM MALIGNANT | 12 0.12 57.24 NEPHROGENIC ANAEMIA | 1 0.01 57.25 NEPHROLITHIASIS | 1 0.01 57.26 NEPHROPATHY | 2 0.02 57.28 NERVE COMPRESSION | 1 0.01 57.29 NERVE INJURY | 2 0.02 57.31 NERVOUS SYSTEM DISORDER | 1 0.01 57.32 NERVOUSNESS | 3 0.03 57.35 NEURALGIA | 17 0.17 57.52 NEUROBLASTOMA | 2 0.02 57.54 NEUROENDOCRINE CARCINOMA | 1 0.01 57.55 NEUROENDOCRINE TUMOUR | 1 0.01 57.56 NEUROGENIC BLADDER | 2 0.02 57.58 NEUROPATHY PERIPHERAL | 24 0.24 57.82 NEUROSIS | 5 0.05 57.87 NEUTROPENIA | 8 0.08 57.95 NEUTROPHIL COUNT INCREASED | 1 0.01 57.96 NICOTINE DEPENDENCE | 1 0.01 57.97 NIGHTMARE | 1 0.01 57.98 NON-HODGKIN'S LYMPHOMA | 23 0.23 58.21 NON-SMALL CELL LUNG CANCER | 51 0.51 58.72 NON-SMALL CELL LUNG CANCER METASTATIC | 4 0.04 58.76 NON-SMALL CELL LUNG CANCER STAGE III | 3 0.03 58.79 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 58.82 NOONAN SYNDROME | 1 0.01 58.83 NUCLEAR MAGNETIC RESONANCE IMAGING | 8 0.08 58.91 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 58.93 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 4 0.04 58.97 NUTRITIONAL SUPPORT | 7 0.07 59.04 OBLITERATIVE BRONCHIOLITIS | 7 0.07 59.11 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 59.14 OCULAR HYPERAEMIA | 1 0.01 59.15 OCULAR HYPERTENSION | 5 0.05 59.20 OEDEMA | 4 0.04 59.24 OEDEMA PERIPHERAL | 1 0.01 59.25 OESOPHAGEAL ADENOCARCINOMA | 2 0.02 59.27 OESOPHAGEAL CARCINOMA | 2 0.02 59.29 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 59.30 OESTROGEN REPLACEMENT THERAPY | 1 0.01 59.31 OFF LABEL USE | 5 0.05 59.36 ONYCHOMYCOSIS | 3 0.03 59.39 OPPORTUNISTIC INFECTION PROPHYLAXIS | 1 0.01 59.40 ORAL CONTRACEPTION | 17 0.17 59.57 ORAL HERPES | 1 0.01 59.58 OROPHARYNGEAL PAIN | 2 0.02 59.60 ORTHOSTATIC HYPERTENSION | 1 0.01 59.61 OSTEITIS | 5 0.05 59.66 OSTEITIS DEFORMANS | 1 0.01 59.67 OSTEOARTHRITIS | 7 0.07 59.74 OSTEOPENIA | 13 0.13 59.87 OSTEOPOROSIS | 158 1.58 61.45 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 61.49 OSTEOPOROSIS PROPHYLAXIS | 4 0.04 61.53 OTITIS EXTERNA | 2 0.02 61.55 OVARIAN CANCER | 9 0.09 61.64 OVARIAN CANCER METASTATIC | 1 0.01 61.65 OVARIAN CANCER RECURRENT | 7 0.07 61.72 OVARIAN CYST | 4 0.04 61.76 OVERDOSE | 6 0.06 61.82 OXYGEN SATURATION DECREASED | 1 0.01 61.83 PAIN | 193 1.93 63.76 PAIN IN EXTREMITY | 11 0.11 63.87 PAIN MANAGEMENT | 13 0.13 64.00 PAIN PROPHYLAXIS | 3 0.03 64.03 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 64.04 PANCREATIC CARCINOMA | 1 0.01 64.05 PANCREATITIS | 1 0.01 64.06 PANCREATITIS CHRONIC | 2 0.02 64.08 PANIC ATTACK | 7 0.07 64.15 PANIC DISORDER | 4 0.04 64.19 PARANOIA | 3 0.03 64.22 PARATHYROIDECTOMY | 2 0.02 64.24 PARENTERAL NUTRITION | 1 0.01 64.25 PARKINSON'S DISEASE | 19 0.19 64.44 PARONYCHIA | 2 0.02 64.46 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 6 0.06 64.52 PARTIAL SEIZURES | 2 0.02 64.54 PEPTIC ULCER | 2 0.02 64.56 PERCUTANEOUS CORONARY INTERVENTION | 4 0.04 64.60 PERIARTHRITIS | 2 0.02 64.62 PERIODONTITIS | 1 0.01 64.63 PERITONEAL DIALYSIS | 118 1.18 65.81 PERITONITIS BACTERIAL | 1 0.01 65.82 PHOBIA | 2 0.02 65.84 PHYTOTHERAPY | 1 0.01 65.85 PITUITARY TUMOUR | 1 0.01 65.86 PITUITARY TUMOUR BENIGN | 1 0.01 65.87 PLANTAR FASCIITIS | 1 0.01 65.88 PLATELET COUNT DECREASED | 1 0.01 65.89 PLEURAL MESOTHELIOMA MALIGNANT | 2 0.02 65.91 PLEURISY | 3 0.03 65.94 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 65.96 PNEUMONIA | 10 0.10 66.06 PNEUMONIA ASPIRATION | 1 0.01 66.07 PNEUMONIA BACTERIAL | 2 0.02 66.09 PNEUMONIA PNEUMOCOCCAL | 1 0.01 66.10 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 66.11 PNEUMONITIS | 2 0.02 66.13 PO2 DECREASED | 1 0.01 66.14 POISONING DELIBERATE | 2 0.02 66.16 POLYARTHRITIS | 7 0.07 66.23 POLYCYSTIC OVARIES | 3 0.03 66.26 POLYCYTHAEMIA | 1 0.01 66.27 POLYCYTHAEMIA VERA | 1 0.01 66.28 POLYMYALGIA RHEUMATICA | 1 0.01 66.29 POLYMYOSITIS | 4 0.04 66.33 POLYNEUROPATHY | 1 0.01 66.34 POOR PERIPHERAL CIRCULATION | 1 0.01 66.35 POOR QUALITY SLEEP | 1 0.01 66.36 POST COITAL CONTRACEPTION | 1 0.01 66.37 POST HERPETIC NEURALGIA | 5 0.05 66.42 POST PROCEDURAL CONSTIPATION | 1 0.01 66.43 POST-TRAUMATIC EPILEPSY | 1 0.01 66.44 POST-TRAUMATIC STRESS DISORDER | 5 0.05 66.49 POSTOPERATIVE ANALGESIA | 1 0.01 66.50 POSTOPERATIVE FEVER | 1 0.01 66.51 POSTOPERATIVE WOUND INFECTION | 1 0.01 66.52 PRECOCIOUS PUBERTY | 1 0.01 66.53 PREMEDICATION | 64 0.64 67.17 PREMENSTRUAL SYNDROME | 24 0.24 67.41 PRIMARY AMYLOIDOSIS | 3 0.03 67.44 PROCEDURAL PAIN | 5 0.05 67.49 PROCTALGIA | 1 0.01 67.50 PRODUCT USED FOR UNKNOWN INDICATION | 1,575 15.75 83.25 PRODUCTIVE COUGH | 1 0.01 83.26 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 83.27 PROLACTINOMA | 1 0.01 83.28 PROPHYLACTIC CHEMOTHERAPY | 2 0.02 83.30 PROPHYLAXIS | 178 1.78 85.08 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 10 0.10 85.18 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 32 0.32 85.50 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 6 0.06 85.56 PROPHYLAXIS OF NAUSEA AND VOMITING | 9 0.09 85.65 PROPHYLAXIS URINARY TRACT INFECTION | 1 0.01 85.66 PROSTATE CANCER | 23 0.23 85.89 PROSTATE CANCER METASTATIC | 7 0.07 85.96 PROSTATE CANCER STAGE II | 2 0.02 85.98 PROSTATE CANCER STAGE III | 3 0.03 86.01 PROSTATE CANCER STAGE IV | 6 0.06 86.07 PROSTATE INFECTION | 1 0.01 86.08 PROSTATIC DISORDER | 5 0.05 86.13 PROSTATOMEGALY | 1 0.01 86.14 PROTEUS INFECTION | 3 0.03 86.17 PSEUDOMEMBRANOUS COLITIS | 1 0.01 86.18 PSEUDOMONAL BACTERAEMIA | 1 0.01 86.19 PSEUDOMONAS INFECTION | 4 0.04 86.23 PSORIASIS | 48 0.48 86.71 PSORIATIC ARTHROPATHY | 36 0.36 87.07 PSYCHOTIC DISORDER | 20 0.20 87.27 PULMONARY ARTERIAL HYPERTENSION | 73 0.73 88.00 PULMONARY EMBOLISM | 9 0.09 88.09 PULMONARY HYPERTENSION | 6 0.06 88.15 PULMONARY NECROSIS | 3 0.03 88.18 PULMONARY TUBERCULOSIS | 4 0.04 88.22 PYREXIA | 11 0.11 88.33 RASH | 4 0.04 88.37 RECTAL CANCER | 9 0.09 88.46 RECTAL CANCER METASTATIC | 4 0.04 88.50 RECTAL CANCER RECURRENT | 1 0.01 88.51 REFLUX OESOPHAGITIS | 9 0.09 88.60 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 23 0.23 88.83 RENAL AND PANCREAS TRANSPLANT | 5 0.05 88.88 RENAL CANCER | 11 0.11 88.99 RENAL CANCER METASTATIC | 2 0.02 89.01 RENAL CELL CARCINOMA | 18 0.18 89.19 RENAL CELL CARCINOMA STAGE IV | 1 0.01 89.20 RENAL DISORDER | 1 0.01 89.21 RENAL FAILURE | 7 0.07 89.28 RENAL FAILURE CHRONIC | 15 0.15 89.43 RENAL OSTEODYSTROPHY | 2 0.02 89.45 RENAL PAIN | 1 0.01 89.46 RENAL TRANSPLANT | 31 0.31 89.77 RESPIRATORY DISORDER | 5 0.05 89.82 RESPIRATORY DISTRESS | 4 0.04 89.86 RESPIRATORY TRACT INFECTION | 3 0.03 89.89 RESPIRATORY TRACT INFECTION FUNGAL | 1 0.01 89.90 RESTLESS LEGS SYNDROME | 10 0.10 90.00 RESTLESSNESS | 3 0.03 90.03 RETINAL DETACHMENT | 4 0.04 90.07 RHEUMATOID ARTHRITIS | 285 2.85 92.92 RHINITIS | 7 0.07 92.99 RHINITIS ALLERGIC | 3 0.03 93.02 RHODOCOCCUS INFECTION | 4 0.04 93.06 RIB FRACTURE | 1 0.01 93.07 SACROILIITIS | 1 0.01 93.08 SALIVARY HYPERSECRETION | 2 0.02 93.10 SARCOMA | 6 0.06 93.16 SCAN MYOCARDIAL PERFUSION | 1 0.01 93.17 SCHIZOAFFECTIVE DISORDER | 20 0.20 93.37 SCHIZOPHRENIA | 72 0.72 94.09 SCHIZOPHRENIA, PARANOID TYPE | 3 0.03 94.12 SCIATICA | 1 0.01 94.13 SCLERODERMA | 4 0.04 94.17 SEASONAL ALLERGY | 4 0.04 94.21 SEBORRHOEIC DERMATITIS | 2 0.02 94.23 SECONDARY IMMUNODEFICIENCY | 1 0.01 94.24 SEDATION | 4 0.04 94.28 SEDATIVE THERAPY | 1 0.01 94.29 SELF-MEDICATION | 1 0.01 94.30 SENILE DEMENTIA | 1 0.01 94.31 SENILE OSTEOPOROSIS | 1 0.01 94.32 SEPSIS | 5 0.05 94.37 SERONEGATIVE ARTHRITIS | 2 0.02 94.39 SERUM FERRITIN INCREASED | 1 0.01 94.40 SICKLE CELL ANAEMIA | 5 0.05 94.45 SINUS CONGESTION | 2 0.02 94.47 SINUS DISORDER | 2 0.02 94.49 SINUS HEADACHE | 1 0.01 94.50 SINUSITIS | 13 0.13 94.63 SJOGREN'S SYNDROME | 3 0.03 94.66 SKIN DISORDER | 1 0.01 94.67 SKIN ULCER | 1 0.01 94.68 SLEEP DISORDER | 21 0.21 94.89 SLEEP DISORDER THERAPY | 4 0.04 94.93 SMALL INTESTINE CARCINOMA | 1 0.01 94.94 SMEAR CERVIX ABNORMAL | 1 0.01 94.95 SMOKING CESSATION THERAPY | 29 0.29 95.24 SOCIAL PHOBIA | 2 0.02 95.26 SOMNOLENCE | 4 0.04 95.30 SPINAL COLUMN STENOSIS | 2 0.02 95.32 SPINAL DISORDER | 1 0.01 95.33 SPINAL FUSION SURGERY | 1 0.01 95.34 SPONDYLITIS | 1 0.01 95.35 STAPHYLOCOCCAL INFECTION | 3 0.03 95.38 STEM CELL TRANSPLANT | 26 0.26 95.64 STENT PLACEMENT | 3 0.03 95.67 STOMATITIS | 2 0.02 95.69 STRESS | 2 0.02 95.71 STRESS ECHOCARDIOGRAM | 1 0.01 95.72 SUICIDAL BEHAVIOUR | 2 0.02 95.74 SUICIDE ATTEMPT | 5 0.05 95.79 SUPEROVULATION | 2 0.02 95.81 SUPPLEMENTATION THERAPY | 23 0.23 96.04 SUPRAVENTRICULAR TACHYCARDIA | 5 0.05 96.09 SURGERY | 5 0.05 96.14 SWELLING | 1 0.01 96.15 SYSTEMIC LUPUS ERYTHEMATOSUS | 19 0.19 96.34 T-CELL LYMPHOMA REFRACTORY | 13 0.13 96.47 TACHYARRHYTHMIA | 6 0.06 96.53 TACHYCARDIA | 1 0.01 96.54 TENDONITIS | 1 0.01 96.55 TENSION | 1 0.01 96.56 TENSION HEADACHE | 1 0.01 96.57 THALASSAEMIA BETA | 1 0.01 96.58 THROAT IRRITATION | 1 0.01 96.59 THROMBOCYTOPENIA | 8 0.08 96.67 THROMBOSIS | 6 0.06 96.73 THROMBOSIS PROPHYLAXIS | 30 0.30 97.03 THYMOMA | 1 0.01 97.04 THYROID CANCER | 2 0.02 97.06 THYROID DISORDER | 7 0.07 97.13 THYROID NEOPLASM | 1 0.01 97.14 THYROID OPERATION | 1 0.01 97.15 THYROIDECTOMY | 3 0.03 97.18 THYROIDITIS CHRONIC | 1 0.01 97.19 THYROXINE | 1 0.01 97.20 THYROXINE DECREASED | 1 0.01 97.21 TINEA PEDIS | 1 0.01 97.22 TINNITUS | 1 0.01 97.23 TOBACCO USER | 4 0.04 97.27 TONSILLITIS | 1 0.01 97.28 TOOTH ABSCESS | 2 0.02 97.30 TOOTH DISORDER | 1 0.01 97.31 TOOTH INFECTION | 2 0.02 97.33 TOOTHACHE | 9 0.09 97.42 TOXOPLASMOSIS PROPHYLAXIS | 1 0.01 97.43 TRANSIENT ISCHAEMIC ATTACK | 1 0.01 97.44 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.45 TRANSPLANT | 4 0.04 97.49 TRANSPLANT ABSCESS | 2 0.02 97.51 TRANSPLANT REJECTION | 1 0.01 97.52 TRAUMATIC BRAIN INJURY | 1 0.01 97.53 TREMOR | 4 0.04 97.57 TRICHOTILLOMANIA | 1 0.01 97.58 TRIGEMINAL NEURALGIA | 5 0.05 97.63 TUBERCULIN TEST | 7 0.07 97.70 TUBERCULOSIS | 6 0.06 97.76 TUMOUR EXCISION | 1 0.01 97.77 TYPE 1 DIABETES MELLITUS | 17 0.17 97.94 TYPE 2 DIABETES MELLITUS | 91 0.91 98.85 ULCER | 2 0.02 98.87 UNEVALUABLE EVENT | 2 0.02 98.89 UNRELATED DONOR BONE MARROW TRANSPLAN.. | 1 0.01 98.90 UPPER RESPIRATORY TRACT INFECTION | 20 0.20 99.10 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 99.12 URINARY INCONTINENCE | 4 0.04 99.16 URINARY TRACT INFECTION | 28 0.28 99.44 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 99.45 URINE COLOUR ABNORMAL | 1 0.01 99.46 URTICARIA | 1 0.01 99.47 UTERINE CONTRACTIONS ABNORMAL | 2 0.02 99.49 UTERINE LEIOMYOMA | 1 0.01 99.50 UVEITIS | 4 0.04 99.54 VAGINAL HAEMORRHAGE | 1 0.01 99.55 VAGINAL INFECTION | 5 0.05 99.60 VASCULITIS NECROTISING | 2 0.02 99.62 VENTRICULAR TACHYCARDIA | 1 0.01 99.63 VERTIGO | 1 0.01 99.64 VITAMIN B12 DEFICIENCY | 2 0.02 99.66 VITAMIN SUPPLEMENTATION | 16 0.16 99.82 VOMITING | 1 0.01 99.83 VULVOVAGINAL CANDIDIASIS | 1 0.01 99.84 WALDENSTROM'S MACROGLOBULINAEMIA | 4 0.04 99.88 WEIGHT CONTROL | 1 0.01 99.89 WEIGHT DECREASED | 6 0.06 99.95 WEIGHT LOSS DIET | 1 0.01 99.96 WHEEZING | 1 0.01 99.97 WOUND | 1 0.01 99.98 WOUND COMPLICATION | 1 0.01 99.99 XEROSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015